288297
When enough is too much: Community consent and biospecimen banking
Method: CBPR principals were reviewed identifying consent issues applicable to genetics, individuals, families, communities and over time.
Results: Some genetic issues have yet to be thoroughly discussed in regards to family consent in genetics biobanking. In the case where family members disagree about participation in one time and/ or “forever” consent for biobanking specimen collections, many questions remain unresolved. If male and female siblings participate in biobanking research, are the analyzed results and information conclusive for other members of the family that do not consent to know such information. Do unwelcome disclosures of information create situations for liability or breach of released medical information? What percentage of a family needs to consent for broad based testing? Can families give consent for future tests that may be unknown and unanticipated at the time of consent? Do significant health benefits or treatment options create an obligation to inform? Ethical principles inform consent considerations.
Conclusions: Policy and ethical considerations must consider a wide range of consent issues for banks of biomedical specimens especially when broad permission applies like unlimited time frames. Future breakthroughs may afford testing opportunities unknown at the time of consent. Community or family participation in such studies presents challenges to CBPR principles and scientific protocols for community and family Consent.
Learning Areas:
Diversity and cultureEthics, professional and legal requirements
Planning of health education strategies, interventions, and programs
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related research
Learning Objectives:
List at least three gaps in biobanking consent.
Describe at complex case studies where family and community consent may apply.
Explain Community Based Participatory Research applications as they apply to biobanking.
Discuss the importance of proactively addressing consent when future options and considerations are unknown.
Keyword(s): Bioethics, Research Ethics
Qualified on the content I am responsible for because: With over 30 years public health experience, I am poised to discuss ethical issues that may affect new testing and resarch protocols. Consent issues affecting not only individuals but families and communities need to be addressed in a timely manner.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.